(Q38972595)

English

miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lorraine O'Driscoll

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

object named as

Sweta Rani

2

0 references

Claire Corcoran

1

object named as

Claire Corcoran

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

22 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1320-1334

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Use and assessment of PSA in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Docetaxel-based combination therapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Management of advanced prostate cancer after first-line chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Role of the MRP1/ABCC1 multidrug transporter protein in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Intracellular and extracellular microRNAs in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Serum microRNAs are promising novel biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Exosomal microRNA: a diagnostic marker for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Identifying mRNA, microRNA and protein profiles of melanoma exosomes

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

ALIX/AIP1 is required for NP incorporation into Mopeia virus Z-induced virus-like particles

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Tamm-Horsfall protein and urinary exosome isolation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Astrocytes and Glioblastoma cells release exosomes carrying mtDNA.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MicroRNA expression analysis: techniques suitable for studies of intercellular and extracellular microRNAs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Membrane vesicles as conveyors of immune responses

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MicroRNA expression profiles classify human cancers

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MicroRNA signatures in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MicroRNA and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Detection of microRNA expression in human peripheral blood microvesicles

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Selective release of microRNA species from normal and malignant mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Loss of mir-146a function in hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

miRNA-34a is associated with docetaxel resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22848

21 January 2018

Identifiers

10.1002/PROS.22848

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38972595&oldid=1800018572"